336 related articles for article (PubMed ID: 6817443)
1. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
[TBL] [Abstract][Full Text] [Related]
2. [Factor VIII complex activities in acute leukemia].
Pniejnia-Olszyński W; Lopaciuk S
Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
[TBL] [Abstract][Full Text] [Related]
3. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Chediak J; Peake I; Bloom A
Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
[TBL] [Abstract][Full Text] [Related]
4. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
5. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
Casonato A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
[TBL] [Abstract][Full Text] [Related]
6. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
[TBL] [Abstract][Full Text] [Related]
8. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
Tran TH; Lämmle B; Duckert F
Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
10. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
11. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever.
Molinas FC; Maiztegui JI
Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740
[TBL] [Abstract][Full Text] [Related]
14. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR].
Pfyffer M; Kistler HJ; von Felten A
Schweiz Med Wochenschr; 1983 Oct; 113(40):1456-9. PubMed ID: 6417777
[TBL] [Abstract][Full Text] [Related]
15. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
Ballard JO; Sanders JC; Eyster ME
Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
[TBL] [Abstract][Full Text] [Related]
17. Acquired factor VIII inhibitor.
Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
[TBL] [Abstract][Full Text] [Related]
19. Acquired haemophilia: functional study of antibodies to Factor VIII.
Allain JP; Gaillandre A; Frommel D
Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
[TBL] [Abstract][Full Text] [Related]
20. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
Tran TH; Marbet GA; Duckert F
Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]